Emboline
Santa Cruz, US · Delaware corporation · 1 known investors
Find your way into Emboline
51 people in our graph share verified history with the Emboline team — schools, employers, funds. One of them is your warm intro.
Takaaki Tobaruunlockedknows Mark Caires · together at San Diego State University (overlapped)
×7knows the team · via Santa Clara University
×2knows the team · via San Diego State University
knows the team · via Silk Road Medical, Inc.
knows the team · via Emboline
Emboline develops the Emboliner Embolic Protection System, a cerebral protection device aimed at preventing stroke during transcatheter aortic valve replacement (TAVR) procedures. The company serves interventional cardiologists in the structural heart and cardiovascular medical device market.
Founders & leadership
AB
Amir BelsoninFounder & Chief Technology OfficerAmir Belson is the founder and Chief Technology Officer of Emboline, which develops a cerebral protection device for transcatheter aortic valve replacement procedures. He has founded multiple medtech companies including Neoguide Systems (acquired by Intuitive Surgical), Vascular Pathways (acquired by C.R. Bard), and Zipline Medical (acquired by Stryker), and holds over 750 patents.
MC
Mark CairesinChief Financial OfficerHe has experience in financing and M&A activities, having participated in over $200 million in funding rounds across multiple startups and managed over $50 million in cash and securities; he has also contributed to S1 regulatory filings for medical device companies.
NP
Nicholas PappasNamed on SEC filing
ES
Elton SatuskyNamed on SEC filing
EX
Eric XiaoNamed on SEC filing
JC
J. Casey McGlynnNamed on SEC filing
SR
Scott RussellPresident & CEO
IM
Issam MoussaNamed on SEC filing
PC
Peng ChengNamed on SEC filing
Investors · 1
Funding
SEC filings, press & company announcements$86.9M disclosed across 3 rounds · 2020–2026
- $20MraisedMar 2026 · 2 sources
Trinity Capital (lead)
Source ↗
▶$55.4MraisedJun 2021 · 14 investors · OtherRule 506(b)
▶$55.4MraisedJun 2021 · 14 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Nicholas PappasDirector
- Elton SatuskyExecutive Officer
- Amir BelsonExecutive Officer, Director
- Eric XiaoDirector
- J. Casey McGlynnExecutive Officer
- Scott RussellExecutive Officer, Director
- Issam MoussaDirector
- Peng ChengDirector
- Offering amount
- $60.1M
- Amount sold
- $55.4M
- First sale
- May 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$11.6MraisedFeb 2021 · 80 investors · OtherRule 506(b)
▶$11.6MraisedFeb 2021 · 80 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Scott RussellExecutive Officer, Director
- J. Casey McGlynnExecutive Officer
- Issam D. MoussaDirector
- Amir BelsonExecutive Officer, Director
- William DaiDirector
- Elton SatuskyExecutive Officer
- Peng ChengDirector
- Offering amount
- $15M
- Amount sold
- $11.6M
- First sale
- Aug 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Boston Scientific7 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Rf Surgical6 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Emblok4 shared keywordsEmblok develops the Emblok 360° whole body embolic protection system, a medical device used during left heart procedures such as TAVR to block and capture emboli and debris. It aims to reduce the risk of procedure-related strokes and damage to the heart, kidneys, and intestines for physicians and patients.
Companies competing with Emboline for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Emboline do?
- Emboline develops the Emboliner Embolic Protection System, a cerebral protection device aimed at preventing stroke during transcatheter aortic valve replacement (TAVR) procedures. The company serves interventional cardiologists in the structural heart and cardiovascular medical device market.
- Who founded Emboline?
- Emboline was founded by Amir Belson.
- Who are Emboline's investors?
- Emboline's investors include Trinity Capital.
- How much funding has Emboline raised?
- Emboline has disclosed $86.9M raised across 3 rounds.
- Where is Emboline headquartered?
- Emboline is headquartered in Santa Cruz, US.